Cargando…
Efficacy of Locally Administered 1.2% Rosuvastatin Gel in Patients with Periodontitis: A Randomized Placebo Controlled Clinical Trial
Objective Periodontitis initiation and progression are a result of host immune inflammatory response to oral pathogens. Several pharmacological agents are being delivered locally, to improve periodontal health. Hence, the present randomized placebo controlled clinical trial is designed to check the...
Autores principales: | Chatterjee, Debopriya, Kapoor, Anjali, Vijay, Sharmistha, Sobti, Geetika, Kara, Dheeraj, Thanvi, Jaishree |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Private Ltd.
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635963/ https://www.ncbi.nlm.nih.gov/pubmed/31170754 http://dx.doi.org/10.1055/s-0039-1688522 |
Ejemplares similares
-
Comparative Evaluation of Autogenous Bone Graft and Autologous Platelet-Rich Fibrin with and Without 1.2 mg in situ Rosuvastatin Gel in the Surgical Treatment of Intrabony Defect in Chronic Periodontitis Patients
por: Gautam, Kompal, et al.
Publicado: (2022) -
Clinical efficacy of amino bisphosphonate on periodontal disease status in postmenopausal women: Randomized double-blind placebo-controlled trial
por: Gupta, Shikha, et al.
Publicado: (2020) -
Psychometric approach to evaluate periodontal disease using Revised Illness Perception Questionnaire
por: Ali, A. Rizwan, et al.
Publicado: (2022) -
Impact of dental considerations on the quality of life of oral cancer patients
por: Thanvi, Jaishree, et al.
Publicado: (2014) -
Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020)